PHARMACY

CVS sends out call for children’s hands-on art programs

BY Antoinette Alexander

WOONSOCKET, R.I. CVS Caremark All Kids Can and VSA arts, an international nonprofit organization that supports arts programming in schools and communities, have announced a national call for children’s art.

This initiative, themed “Celebrating Who I Am,” invites young people with and without disabilities across the nation to create visual art about their interests, talents and dreams. All artwork submitted by March 6, 2009 will be included in an online art gallery. One piece of art from each state and the District of Columbia will be displayed summer 2009 at Union Square in Washington DC as part of a children?s art exhibition. Ten representatives of the exhibition will be selected to travel to Washington to be honored at a reception on Capitol Hill.

“CVS Caremark is excited to partner again this year with VSA arts on this initiative,” stated Eileen Howard Dunn, senior vice president of corporate communications and community relations for CVS Caremark. “The arts provide a powerful opportunity for children of all levels of abilities to express themselves and to learn, All Kids Can CREATE! encourages children to discover themselves as artists and works toward building inclusion.”

The call for art is part of VSA arts and CVS Caremark’s yearlong campaign, All Kids Can CREATE! The program includes the call for art, artist-in-residence programs in schools that will expand access and document learning through the arts for students with disabilities, and community volunteer activities with CVS Caremark employees that engage their communities and/or schools in building inclusive environments.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

HealthPartners site helps Minneapolis area patients estimate healthcare costs

BY Alaric DeArment

BLOOMINGTON, Minn. A healthcare organization has launched a Web site that quotes prices for 83 procedures at the primary care and radiology centers in its network in the Minneapolis-St. Paul metropolitan area.

HealthPartners announced the launch Tuesday. The price listings are in the ?Find a Provider/Clinic? section of its Web site, www.healthpartners.com.

The prices listed are for five high-volume service categories, including office visits, immunizations and vaccines, lab services, X-rays and CTs and MRIs. For example, a wrist X-ray at one of the clinics costs $61.60, while an influenza test costs $29.18.

“This is an important step forward in transparency because the information we provide is for specific prices rather than a range,” HealthPartners senior vice president for customer service and product innovation Scott Aebischer said. “This information is particularly useful for members who are paying out-of-pocket fees.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA challenges Bayer’s TV commercial claims about Yaz

BY Alaric DeArment

NEW YORK The Food and Drug Administration told Bayer in a letter Tuesday that two of the company’s TV commercials for its premenstrual dysphoric disorder drug Yaz are misleading.

The FDA said one commercial suggests the drug is approved for treating post-menopausal syndrome by saying it treats irritability, moodiness and bloating—symptoms common to PMDD and PMS. That commercial, which featured women hitting balloons while singing “We’re not gonna take it,” has been pulled.

The second commercial had the song “Good-Bye to You” and women releasing balloons with symptoms written on them. The FDA said evidence has not demonstrated that Yaz eliminates symptoms, even though the commercial suggests that it does.

Yaz (drospirenone and ethinyl estradiol) had global sales of $1.42 billion in 2007, according to Bayer financial data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?